Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry

Real-World Experience with Tofacitinib in IBD at a Tertiary Center

(2019) Roni Weisshof et al.   DIGESTIVE DISEASES AND SCIENCES

Systematic review and meta-analysis: efficacy and safety of oral Janus kinase inhibitors for inflammatory bowel disease

(2019) Christopher Ma et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Tofacitinib Treatment is Associated with Modest and Reversible Increases in Serum Lipids in Patients with Ulcerative Colitis

(2019) Bruce E. Sands et al.   Clinical Gastroenterology and Hepatology

Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study

(2019) Vince B C Biemans et al.   Journal of Crohns & Colitis

Venous thromboembolic events in the tofacitinib ulcerative colitis clinical development programme

(2019) William J. Sandborn et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Efficacy and safety of tofacitinib dose de-escalation and dose escalation for patients with ulcerative colitis: results from OCTAVE Open

(2019) Bruce E. Sands et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Real-world evidence of tofacitinib effectiveness and safety in patients with refractory ulcerative colitis

(2019) Loriane Lair-Mehiri et al.   DIGESTIVE AND LIVER DISEASE

Tofacitinib Induction Therapy Reduces Symptoms Within 3 Days for Patients With Ulcerative Colitis

(2018) Stephen Hanauer et al.   Clinical Gastroenterology and Hepatology

Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials

(2018) William J. Sandborn et al.   Clinical Gastroenterology and Hepatology

Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

(2017) William J. Sandborn et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist

(2016) Christina Charles-Schoeman et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

(2015) R. Bissonnette et al.   BRITISH JOURNAL OF DERMATOLOGY

Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial

(2015) Hervé Bachelez et al.   LANCET

Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases

(2014) James D. Clark et al.   JOURNAL OF MEDICINAL CHEMISTRY

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

(2012) Christina Ha et al.   Clinical Gastroenterology and Hepatology